Table 5 Direct cost of diagnosis and treatment per patient with DR
From: Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
Direct cost of screening programme to detect a patient | Direct cost of diagnosis per patient | Yearly direct cost of treatment per patient | Yearly direct cost of follow up per patient | |
|---|---|---|---|---|
Any DR | €482.32 ± 35.14 | €100.51 ± 23.75 | €184.67 ± 19.47 | €288.15 ± 37.93 |
Sight threatening DR | €1528.26 ± 114.94 | €167.91 ± 7.69 | €2191 ± 15.51 | €441.37 ± 10.83 |
DMO | €1824.82 ± 108.26 | €132.24 ± 8.17 | €777.09 ± 49.45a | €509.42 ± 20.28a |
€7153.62 ± 212.15b | €473.56 ± 62.69b | |||
Mild DR | €443 ± 61.21 | €79.45 ± 8.05 | €139.27 ± 27.88 | €145 ± 18.65 |
Moderate DR | €4995,93 ± 468,29 | €108.12 ± 31.37 | €5319.01 ± 1307.04 | €448.76 ± 79.35 |
Severe DR | €7452,26 ± 698,53 | €175.23 ± 48.21 | €7970,93 ± 897.45 | €475.13 ± 77.65 |
Proliferative | €94,332,48 ± 8842,19 | €244.97 ± 87.16 | €12177.74 ± 1027.22 | €995.78 ± 97.47 |